The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros

Oncogene

Volumn 27, Issue 20, 2008, Pages 2886-2896

  Greif, P A ^a   Tizazu, B ^a   Krause, A ^a   Kremmer, E ^b   Bohlander, S K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

AF10; CALM AF10; Ikaros; Leukemia; Translocation

Indexed keywords

CALM AF10 FUSION PROTEIN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; IKAROS TRANSCRIPTION FACTOR; ISOPROTEIN; LEUCINE ZIPPER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AF10 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CALM GENE; CELLULAR DISTRIBUTION; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FIBROBLAST; GENE; GENE EXPRESSION; GENE FUSION; GENE MAPPING; HUMAN; HUMAN CELL; IKAROS GENE; IMMUNOPRECIPITATION; LEUKEMOGENESIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOMA; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM; YEAST;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; HUMANS; IKAROS TRANSCRIPTION FACTOR; LEUKEMIA; LYMPHOCYTES; MICE; MOLECULAR SEQUENCE DATA; MONOMERIC CLATHRIN ASSEMBLY PROTEINS; NIH 3T3 CELLS; ONCOGENE PROTEINS, FUSION; SUBCELLULAR FRACTIONS; TRANSCRIPTION FACTORS;

MURINAE;

EID: 42949094651     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210945     Document Type: Article

References (47)

1. Andrews NC, Faller DV. (1991). A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 2499.
2. Archangelo LF, Glasner J, Krause A, Bohlander SK. (2006). The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10. Oncogene 25: 4099-4109.
3. Bohlander SK, Muschinsky V, Schrader K, Siebert R, Schlegelberger B, Harder L et al. (2000). Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients. Leukemia 14: 93-99.
4. Brown KE, Guest SS, Smale ST, Hahm K, Merkenschlager M, Fisher AG. (1997). Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 91: 845-854.
5. Caudell D, Zhang Z, Chung YJ, Aplan PD. (2007). Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice. Cancer Res 67: 8022-8031.
6. Chaplin T, Ayton P, Bernard OA, Saha V, Della VV, Hillion J et al. (1995). A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia. Blood 85: 1435-1441.
7. Cobb BS, Morales-Alcelay S, Kleiger G, Brown KE, Fisher AG, Smale ST. (2000). Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev 14: 2146-2160.
8. Debernardi S, Bassini A, Jones LK, Chaplin T, Linder B, de Bruijn DR et al. (2002). The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex. Blood 99: 275-281.
9. Deshpande AJ, Cusan M, Rawat VP, Reuter H, Krause A, Pott C et al. (2006). Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia. Cancer Cell 10: 363-374.
10. DiMartino JF, Ayton PM, Chen EH, Naftzger CC, Young BD, Cleary ML. (2002). The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood 99: 3780-3785.
11. Dreyling MH, Martinez-Climent JA, Zheng M, Mao J, Rowley JD, Bohlander SK. (1996). The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc Natl Acad Sci USA 93: 4804-4809.
12. Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S et al. (1994). The Ikaros gene is required for the development of all lymphoid lineages. Cell 79: 143-156.
13. Georgopoulos K, Moore DD, Derfler B. (1992). Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 258: 808-812.
14. Gomez-del Arco P, Koipally J, Georgopoulos K. (2005). Ikaros SUMOylation: switching out of repression. Mol Cell Biol 25: 2688-2697.
15. Gomez-del Arco P, Maki K, Georgopoulos K. (2004). Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition. Mol Cell Biol 24: 2797-2807.
16. Hahm K, Ernst P, Lo K, Kim GS, Turck C, Smale ST. (1994). The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol Cell Biol 14: 7111-7123.
17. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. (2002). Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18(Suppl 1): S96-S104.
18. Kim J, Sif S, Jones B, Jackson A, Koipally J, Heller E et al. (1999). Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 10: 345-355.
19. Kobayashi H, Thirman MJ, Rowley JD. (1995). U937 cell line has a t(10;11)(p13-14;q14-21) rather than a deletion of 11q. Genes Chromosomes Cancer 13: 217-218.
20. Koipally J, Heller EJ, Seavitt JR, Georgopoulos K. (2002). Unconventional potentiation of gene expression by Ikaros. J Biol Chem 277: 13007-13015.
21. Linder B, Gerlach N, Jackle H. (2001). The Drosophila homolog of the human AF10 is an HP1-interacting suppressor of position effect variegation. EMBO Rep 2: 211-216.
22. Linder B, Newman R, Jones LK, Debernardi S, Young BD, Freemont P et al. (2000). Biochemical analyses of the AF10 protein: the extended LAP/PHD-finger mediates oligomerisation. J Mol Biol 299: 369-378.
23. Martin DG, Baetz K, Shi X, Walter KL, Macdonald VE, Wlodarski MJ et al. (2006). The Yng1p PHD finger is a methyl-histone binding module that recognizes lysine 4 methylated histone H3. Mol Cell Biol 26: 7871-7879.
24. Mellor J. (2006). It takes a PHD to read the histone code. Cell 126: 22-24.
25. Molnar A, Georgopoulos K. (1994). The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol 14: 8292-8303.
26. Nietfeld W, Meyerhans A. (1996). Cloning and sequencing of hIk-1, a cDNA encoding a human homologue of mouse Ikaros/LyF-1. Immunol Lett 49: 139-141.
27. Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, Coffield VM et al. (2005). hDOT1L links histone methylation to leukemogenesis. Cell 121: 167-178.
28. Okada Y, Jiang Q, Lemieux M, Jeannotte L, Su L, Zhang Y. (2006). Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L. Nat Cell Biol 8: 1017-1024.
29. Olivero S, Maroc C, Beillard E, Gabert J, Nietfeld W, Chabannon C et al. (2000). Detection of different Ikaros isoforms in human leukaemias using real-time quantitative polymerase chain reaction. Br J Haematol 110: 826-830.
30. Payne KJ, Huang G, Sahakian E, Zhu JY, Barteneva NS, Barsky LW et al. (2003). Ikaros isoform x is selectively expressed in myeloid differentiation. J Immunol 170: 3091-3098.
31. Payne KJ, Nicolas JH, Zhu JY, Barsky LW, Crooks GM. (2001). Cutting edge: predominant expression of a novel Ikaros isoform in normal human hemopoiesis. J Immunol 167: 1867-1870.
32. Rabbitts TH. (1994). Chromosomal translocations in human cancer. Nature 372: 143-149.
33. Rebollo A, Schmitt C. (2003). Ikaros, Aiolos and Helios: transcription regulators and lymphoid malignancies. Immunol Cell Biol 81: 171-175.
34. Ronni T, Payne KJ, Ho S, Bradley MN, Dorsam G, Dovat S. (2007). Human ikaros function in activated T cells is regulated by coordinated expression of its largest isoforms. J Biol Chem 282: 2538-2547.
35. Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, Okuno Y et al. (2004). Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet 36: 624-630.
36. Rowley JD. (1990). Recurring chromosome abnormalities in leukemia and lymphoma. Semin Hematol 27: 122-136.
37. Schoch C, Kohlmann A, Schnittger S, Brors B, Dugas M, Mergenthaler S et al. (2002). Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci USA 99: 10008-10013.
38. Sun L, Crotty ML, Sensel M, Sather H, Navara C, Nachman J et al. (1999a). Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia. Clin Cancer Res 5: 2112-2120.
39. Sun L, Goodman PA, Wood CM, Crotty ML, Sensel M, Sather H et al. (1999b). Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia. J Clin Oncol 17: 3753-3766.
40. Sun L, Heerema N, Crotty L, Wu X, Navara C, Vassilev A et al. (1999c). Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. Proc Natl Acad Sci USA 96: 680-685.
41. Sun L, Liu A, Georgopoulos K. (1996). Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J 15: 5358-5369.
42. Tebar F, Bohlander SK, Sorkin A. (1999). Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol Biol Cell 10: 2687-2702.
43. Trinh LA, Ferrini R, Cobb BS, Weinmann AS, Hahm K, Ernst P et al. (2001). Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev 15: 1817-1832.
44. Westman BJ, Mackay JP, Gell D. (2002). Ikaros: a key regulator of haematopoiesis. Int J Biochem Cell Biol 34: 1304-1307.
45. Winandy S, Wu P, Georgopoulos K. (1995). A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83: 289-299.
46. Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J et al. (2006). A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442: 86-90.
47. Yoshida T, Ng SY, Zuniga-Pflucker JC, Georgopoulos K. (2006). Early hematopoietic lineage restrictions directed by Ikaros. Nat Immunol 7: 382-391.